ArticleBritish journal of haematology2025

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma.

Shyam Srinivasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.